The effects of dopexamine in bupivacaine and ropivacaine induced cardiotoxicity in isolated rat heart

Saudi Medical Journal

Volumn 27, Issue 8, 2006, Pages 1194-1198

  Bilir, Ayten ^a   Yelken, Birgul ^a   Kaygisiz, Ziya ^a   Senturk, Yilmaz ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; DOPEXAMINE; ROPIVACAINE; AMIDE; DOPAMINE; DRUG DERIVATIVE; LOCAL ANESTHETIC AGENT; VASODILATOR AGENT;

ARTICLE; CARDIOTOXICITY; CHRONOTROPISM; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; DRUG MECHANISM; DRUG SAFETY; HEART CONTRACTION; HEART RATE; INOTROPISM; ISOLATED HEART; NONHUMAN; OUTCOME ASSESSMENT; RAT; ANIMAL; HEART; PHYSIOLOGY; TIME; WISTAR RAT;

AMIDES; ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; DOPAMINE; HEART; MYOCARDIAL CONTRACTION; RATS; RATS, WISTAR; TIME FACTORS; VASODILATOR AGENTS;

EID: 34447253103     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Carpenter RL, Mackey DC. Local Anesthetics. In: Barash PF, Cullen BF, Stoeltling RK, editors. Clinical Anesthesia. Philadelphia (PA): Lippincott Raven; 1996. p. 413-440.
2. Groban L, Deal D, Vernon JC, James RL, Butterworth J. Ventricular arrhythmias with or without programmed electrical stimulation after incremental overdosage with lidocaine, bupivacaine, levobupivacaine and ropivacaine. Anesth Analg 2000; 91: 1103-1111
3. Hyman SA, Kinney WW, Horn JL, Skelley CC, Kambam JR. Nimodipine reduces the toxicity of intravenous bupivacaine in rats. Anesth Analg 1992; 74: 851-855.
4. Mather LE, Copeland SE, Ladd LA. Acute toxicity of local anesthetics: underlying pharmacokinetic and pharmacodynamic concepts. Reg Anesth Pain Med 2005; 30: 553-566.
5. Santos AC, Arthur GR, Pedersen H, Morishima HO, Finster M, Covino BG. Systemic toxicity of ropivacaine during ovine pregnancy. Anesthesiology 1991; 75: 137-141.
6. Owen MD, Angelo R, Gerancher JC, Thompson JM, Foss ML, Babb JD, et al. 0.125 % Ropivacaine is similar to 0.125% bupivacaine for labor analgesia using patient-controlled epidural infusion. Anesth Analg 1998; 86: 527-530.
7. Zhang S, Yao S, Li Q. Effects of ropivacaine and bupivacaine on rabbit myocardial energetic metabolism and mitochondria oxidation. J Huazhong Univ Sci Technolog Med Sci 2003; 23: 178-179, 183.
8. Boyd O, Grounds RM, Bennett ED. The use of dopexamine hydrochloride to increase oxygen delivery perioperatively. Anesth Analg 1993; 76: 372-375.
9. Morgan P. The role of vasopressors in the management of hypotension induced by spinal and epidural anesthesia. Can J Anaesth 1994; 41: 404-413.
10. Mazoit J X, Decaux A, Bouaziz H, Edouard A. Comparative ventricular electrophysiologic effect of racemic bupivacaine, levobupivacaine, and ropivacaine on the isolated rabbit heart. Anesthesiology 2000; 93: 784-792.
11. Miller RD. Local anesthetics. In: Katzung BG, editor. Basic and clinical pharmacology, Seventh ed. Stanford Connecticut: Appleton & Lange; 1990. p. 425-433.
12. Adsan H, Tulunay M, Onoran O. The effect of verapamil and nimodipine on bupivacaine-induced cardiotoxicity in rats: An in vivo and in vitro study. Anesth Analg 1998; 86: 818-823.
13. Feldman HS, Arthur GR, Pitkanen M, Hurley M, Doucette AM, Covino BG. Treatment of acute systemic toxicity after the rapid intravenous injection of ropivacaine and bupivacaine in the conscious dog. Anesth Analg 1991; 73: 373-378.
14. Fujita Y, Endoh S, Yasukawa T, Sari A. Lidocaine increases the ventricular fibrillation threshold during bupivacaine-induced cardiotoxicity in pigs. Br J Anaesth 1998; 80: 218-222.
15. Mazoit JX, Boico O, Samii K. Myocardial uptake of bupivacaine: II. Pharmacokinetics and pharmacodynamics of bupivacaine enantiomers in the isolated perfused rabbit heart. Anesth Analg 1993; 77: 477-480.
16. Zapata-Sudo G, Trachez MM, Sudo RT, Nelson TE. Is comparative cardiotoxicity of S(-) and R(+) bupivacaine related to enantiomer-selective inhibition of L-Type calcium channels? Anesth Analg 2001; 92: 496-501.
17. Graf BM, Martin E, Bosnjak Z J, Stowe DF. Stereospecific effect of bupivacaine isomers on atrioventricular conduction in the isolated perfused guinea pig heart. Anesthesiology 1997; 86: 410-419.
18. Dony P, Gautier P, De Kock M. The comparative toxicity of ropivacaine and bupivacaine at equipotent doses in rats. Anesth Analg 2000; 91: 1489-1492.
19. Graf BM, Abraham I, Eberbach N, Kunst G, Stowe DF, Martin E. Differences in cardiotoxicity of bupivacaine and ropivacaine are the result of physicochemical and stereoselective properties. Anesthesiology 2002; 96:1427-1434.
20. Brown RA, Dixon J, Farmer JB, Hall JR, Humpries RG, Ince F, et al. Dopexamine: A novel agonist at peripheral dopamine receptors and b2-adrenoceptors. Br J Pharmacol 1985; 85: 599-608.
21. Neustein S M, Dimich I, Sampson I, Sadeghi A, Mezrow C, Shiang H. Arrhythmogenic potential of dopexamine hydrochloride during halothane anesthesia in dogs. Can J Anesth 1994; 41: 542-546.
22. Leier C V, Binkley P F, Carpenter J, Randolph PH, Unwerferth DV. Cardiovascular pharmacology of dopexamine in low output congestive heart failure. Am J Cardiol 1988; 62: 94-99.
23. Perrin G, Papazian L, Martin C. Dopexamine: A new dopaminergic agonist. Ann Fr Anesth Reanim 1993; 12: 308-320.